| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hcw Biologics Inc. (HCWB) has 3 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. HCWB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 615.8K | $686.6K | - | |
| Dir | 203.4K | $226.8K | - | |
| CFO | 57.2K | $63.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2021 | Rhode Peter | See Remarks | Buy | 12,500 | $8.00 | $100,000.00 | +36.5% | -42.6% | -50.1% | |
| Jul 22, 2021 | Flowers Lee | SVP Of Business Development | Buy | 31,250 | $8.00 | $250,000.00 | +85.8% | -42.6% | -50.1% | |
| Jul 22, 2021 | Byam Rebecca | Chief Financial Officer | Buy | 25,000 | $8.00 | $200,000.00 | +92.6% | -42.6% | -50.1% | |
| Jul 22, 2021 | Garrett Scott T | Director | Buy | 125,000 | $8.00 | $1,000,000.00 | New | -42.6% | -50.1% |